HK inno.N Corporation (195940.KQ)

HK inno.N Corporation (195940.KQ) — VMCI valuation read

HK inno.N Corporation sits at VMCI 60/100, with the Healthcare sector median at 50. That 10-point spread is the first thing to note on 195940.KQ: it tells the reader the composite is favorable before any single ratio is examined, and the mid-cap tier sets the comparison set.

Form 4 disclosures on 195940.KQ are blank for the trailing 30 days. With the insider channel offline, the EV/EBITDA delta, free-cash-flow trajectory, and the next earnings print do the talking.

**Investor frame.** The Value read on 195940.KQ: 195940.KQ trades at 20.0x earnings, 11% above the Healthcare median of 18.0x, with EV/EBITDA at 13.0x against 12.0x. The Quality read: ROIC of 8.0% trails the Healthcare median (10.0%) by 2.0pp. The Risk read: net debt to EBITDA of 0.2x leaves covenant headroom, anchoring the bear scenario on a measurable balance-sheet metric.

195940.KQ fell 3.7% over the trailing 7 days, with a -15.4% read on a 30-day basis.